Veteran investor and operating executive focused on growth-stage technology and fintech companies, with experience across corporate strategy, M&A and capital markets. Matthew Francis Dean is known for leading strategic investments, taking board seats and executing operational turnarounds at portfolio companies, combining deal experience with hands-on operating responsibilities. Holds graduate and undergraduate degrees with a finance and strategy orientation and maintains an active advisory and angel investing presence.
Veteran investor and operating executive focused on growth-stage technology and fintech companies, with experience across corporate strategy, M&A and capital markets. Matthew Francis Dean is known for leading strategic investments, taking board seats and executing operational turnarounds at portfolio companies, combining deal experience with hands-on operating responsibilities. Holds graduate and undergraduate degrees with a finance and strategy orientation and maintains an active advisory and angel investing presence.
Focuses on growth-stage technology and fintech opportunities where strategic capital and operator-led guidance accelerate scale. Prioritizes investments with clear product-market fit, recurring revenue models and defensible unit economics, then partners actively through board roles and hands-on operational support. Capital allocation favors equity in follow-on rounds to preserve upside while using disciplined valuation thresholds and milestone-driven tranche commitments. Time horizon is multi-year, targeting transformational growth and exit via strategic sale or IPO; risk managed through concentrated expertise, operational intervention and selective syndication.
Focuses on growth-stage technology and fintech opportunities where strategic capital and operator-led guidance accelerate scale. Prioritizes investments with clear product-market fit, recurring revenue models and defensible unit economics, then partners actively through board roles and hands-on operational support. Capital allocation favors equity in follow-on rounds to preserve upside while using disciplined valuation thresholds and milestone-driven tranche commitments. Time horizon is multi-year, targeting transformational growth and exit via strategic sale or IPO; risk managed through concentrated expertise, operational intervention and selective syndication.
| Trades 688 | Longs Won 398/688 57% | Profit Factor 2.74 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $928,882.22 |
| Average Win $209,265.79 | Best Trade (Jun 30) $20.3M | Sharpe Ratio -5.1 |
| Average Loss -$104,819.73 | Worst Trade (Oct 15) -$8.77M | Z-Score 3.44 (99.94%) |
| Commissions $0 | Avg. Trade Length 9m 3w 1d | Expectancy $76,875.09 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.25% |
| Consecutive Losing Trades | 3,058 | 2,752 | 2,446 | 2,141 | 1,835 | 1,529 | 1,223 | 917 | 612 | 306 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 27,509 | $5.92M | $9.5M | - | $3.58M | 60.57% | +0.98% |
ABBV AbbVie Inc. | 1,635 | $295,948.9 | $467,184.9 | - | $171,236 | 57.86% | +0.826% |
ABT Abbott Laboratories | 675 | $81,556.78 | $70,929 | - | -$10,627.78 | -13.03% | +0.382% |
ACN Accenture plc Class A | 245 | $60,417 | $55,681.15 | - | -$4,735.85 | -7.84% | +1.045% |
ADBE Adobe Inc. | 15 | $5,803.2 | $3,700.8 | - | -$2,102.4 | -36.23% | -1.967% |
AEM Agnico Eagle Mines Limited | 750 | $126,295 | $143,677.5 | - | $17,382.5 | 13.76% | +2.138% |
AER AerCap Holdings N.V. | 795 | $96,195 | $117,282.37 | - | $21,087.37 | 21.92% | +1.1% |
AG First Majestic Silver Corp | 4,700 | $57,704 | $76,492.5 | - | $18,788.5 | 32.56% | +1.15% |
AGI Alamos Gold Inc. | 3,300 | $115,004 | $107,184 | - | -$7,820 | -6.8% | +1.563% |
ALC Alcon Inc. | 400 | $29,762.67 | $26,644 | - | -$3,118.67 | -10.48% | +0.045% |
AMD Advanced Micro Devices, Inc. | 100 | $15,264.06 | $54,367 | - | $39,102.94 | 256.18% | -3.301% |
AMT American Tower Corporation | 1,058 | $230,220.8 | $194,391.63 | - | -$35,829.17 | -15.56% | +1.31% |
AMZN Amazon.com Inc | 25,400 | $5.58M | $6.47M | - | $886,416.2 | 15.88% | -0.047% |
APD Air Products and Chemicals, Inc. | 220 | $62,027.78 | $66,149.6 | - | $4,121.82 | 6.65% | +1.376% |
APH Amphenol Corporation | 936 | $29,583.81 | $75,563.28 | - | $45,979.47 | 155.42% | -0.933% |
AU AngloGold Ashanti plc | 500 | $35,165 | $46,715 | - | $11,550 | 32.85% | +2.031% |
AZN AstraZeneca PLC American Depositary Shares | 21,991 | $4.27M | $3.66M | - | -$617,169.16 | -14.44% | -0.264% |
BABA Alibaba Group Holding Limited SP ADR | 50 | $5,670.5 | $5,534 | - | -$136.5 | -2.41% | -0.405% |
BAC Bank of America Corporation | 33,295 | $1.64M | $1.75M | - | $107,769.2 | 6.57% | +1.509% |
BDX Becton, Dickinson and Company | 561 | $82,548.91 | $108,654.48 | - | $26,105.57 | 31.62% | -0.041% |